INSIDER · CIK 2027261
Garfield Alastair
Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$913KSold on the market
1Companies
Aug 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 202617:57 | Aug 13, 2026 | RYTMRHYTHM PHARMACEUTICALS, INC. | Chief Scientific Officer | S · Sell10b5-1 | $117.57 | −7,763 | 2,295 | -77% | −$913K |